Preference of herbal therapies: Cost of illness and cost benefit analysis for major diseases in the city of Karachi, Pakistan

2Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

The aim of the present study was to assess and compare the allopathic and herbal therapies by carrying out cost of illness and cost benefit analysis after propagation of basic epidemiological and pharmacoeconomic data. The data was recorded from the patient for 3 major diseases, common cold, depression and trauma in all 178 union councils of the city of Karachi, Pakistan, rationalizing the benefits and hence proving the preference of herbal over allopathic therapy. The stratified random sampling (n=178) was used, selecting individual sets of 178 patients for each kind of therapy, utilizing data of epidemiology. The direct and indirect costs were calculated for therapies for selected diseases in patients. However, benefits were analysed by developing uniform method of analysis of costs and benefits, comparing and propagating individual data of union councils on the city level. The differences in costs of illnesses between allopathic and herbal therapies were found to be: Rs.1.51/- billion (USD 14.52/- million), 46.82/- billion (USD 450.19/- million) for depression and Rs.0.14/- billion (Rs.140/- million or USD 1.35/- million) in trauma, respectively. The herbal therapies were proved more effective than allopathic therapies, i.e. 29.85, 11.79 and 4.77 % in cases of common cold, depression and trauma.

References Powered by Scopus

Budget impact analysis - Principles of good practice: Report of the ISPOR 2012 budget impact analysis good practice II task force

797Citations
N/AReaders
Get full text

Model transparency and validation: A report of the ISPOR-SMDM modeling good research practices task force-7

429Citations
N/AReaders
Get full text

A cost-benefit analysis of three older adult fall prevention interventions

113Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cost Effectiveness of Pharmacological and Non-pharmacological Treatments for Depression in Low- and Middle-Income Countries: A Systematic Literature Review

5Citations
N/AReaders
Get full text

Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS)

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ahmad, S. M., Azhar, I., Masroor, D., & Ahmed, N. (2019). Preference of herbal therapies: Cost of illness and cost benefit analysis for major diseases in the city of Karachi, Pakistan. Indian Journal of Pharmaceutical Sciences, 81(5), 885–891. https://doi.org/10.36468/pharmaceutical-sciences.583

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

63%

Researcher 2

25%

Professor / Associate Prof. 1

13%

Readers' Discipline

Tooltip

Economics, Econometrics and Finance 3

43%

Psychology 2

29%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Nursing and Health Professions 1

14%

Save time finding and organizing research with Mendeley

Sign up for free